TGTX
#1003
TG Therapeutics, Inc. - Common Stock
55.0 1 USD
-0.04%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.69%
Monthly Change
+12.27%
6 month change
+86.47%
Year Change
+41.09%
Previous Close
57.1 2
Open
55.0 1
Low
55.0 1
High
55.0 1
Volume
186
Financials
- Market Capitalization 8.42 B
- Employee 399
- Founded 1993
- CEO Michael S Weiss
- Website www.tgtherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG000FVZQY1
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
11.62
Price to sales ratio
7.64
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 983 |  CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 83.67 USD | +0.11% | +0.11% | +141.96% | +103.58% | 8.82 B USD | ||
| 987 |  PRAX Praxis Precision Medicines, Inc. - Common Stock | 314.56 USD | -3.21% | -0.17% | +16.12% | +482.63% | 8.77 B USD | ||
| 1009 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 129.89 USD | -1.16% | -2.04% | +18.08% | +72.89% | 8.35 B USD | ||
| 1012 |  APGE Apogee Therapeutics, Inc. - Common Stock | 133.82 USD | +0.13% | +0.25% | +49.25% | +149.71% | 8.28 B USD |
Frequently asked questions about TG Therapeutics, Inc. - Common Stock
What is the TG Therapeutics, Inc. - Common Stock stock price today?
The current price of TG Therapeutics, Inc. - Common Stock (TGTX) is 55.01. Over the past 24 hours, the stock has changed by -3.69%. Follow the TGTX chart for real-time price dynamics.
What is the stock ticker of TG Therapeutics, Inc. - Common Stock?
TG Therapeutics, Inc. - Common Stock trades under the ticker TGTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is TG Therapeutics, Inc. - Common Stock stock going up?
TGTX has changed by -1.36% over the last week, +12.27% over the last month, and +41.09% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was TG Therapeutics, Inc. - Common Stock net income for the last quarter?
TG Therapeutics, Inc. - Common Stock reported net income of 19.78 M for the last quarter. The previous quarter showed 23.04 M, which means net income changed by -14.15%.
How many employees does TG Therapeutics, Inc. - Common Stock have?
As of the latest available data, TG Therapeutics, Inc. - Common Stock has 399 employees. Workforce size can provide additional context about the company's scale and operations.
What is TG Therapeutics, Inc. - Common Stock EBITDA?
TG Therapeutics, Inc. - Common Stock EBITDA is 34.83 M, and its EBITDA margin is 17%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy TG Therapeutics, Inc. - Common Stock stock?
You can buy TG Therapeutics, Inc. - Common Stock (TGTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in TG Therapeutics, Inc. - Common Stock stock?
Investing in TG Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TGTX chart and related analysis on metatrader.com as part of your research.